Officer in Charge Profile:
- Name: Dr. Clara María Saldívar
- Age: 36 years old
- Specialty: General Physician with a Forensic Specialty
- Position: Head of Procedure and Process Compliance (Responsible for creating and overseeing the compliance of execution protocols)
As Head of Procedure and Process Compliance, my duty is to ensure that every protocol under the ASTEN method is executed with absolute precision, scientific rigor, and strict adherence to regulations, maintaining institutional sobriety regardless of the personal or professional circumstances of the subject being processed. Methodological objectivity must never be compromised, even though the initial human impact resonates deeply within our sensitivity when seeing a fellow member of the medical community cross the line of duty to the sanction bench.
Below is the expanded technical chronology of the events recorded during the procedure according to the photographic sequence:
- Preparation and Spiritual Assistance (Image 1 and Image 2): The protocol began in the temporary holding area. Prior to transfer, the spiritual assistance of the prison chaplain was permitted (Image 1), ensuring compliance with ethical rights prior to sentence enforcement. Moments later, assigned security proceeded with the restraint and formal transfer of the inmate (Image 2), identified as a member of the medical guild, wearing a duty clinical uniform by my autorization.
2.Entry into the Execution Chamber and Restraint (Image 3 and Image 4): At the scheduled time, the inmate entered the main execution chamber flanked by security guards and under my direct supervision (Image 3). She was positioned and mechanically restrained in the clinical protocol chair, firmly securing the containment straps across the torso, arms, and lower extremities to prevent any sudden movement during the infusion (Image 4).
3.Vital Signs Verification and ASTEN Infusion Protocol (Image 5, Image 6, Image 7, and Image 8): Once immobilized and connected to the vital signs monitor, I personally verified the intravenous line and baseline parameters (Image 5). The ASTEN method was administered strictly and sequentially:
- Phase 1 (Induction and Vascular Relaxation): The initial combination of Tramadol (as a transition analgesic and central nervous system modulator) and Terazosin (for vascular smooth muscle relaxation and blood pressure control) was administered. Image 6 records the onset of somatic response and initial pharmacological assimilation.
- Phase 2 (Neuromuscular Blockade): This was followed by the intravenous administration of Vecuronio (Image 7), a non-depolarizing neuromuscular blocking agent that induces complete skeletal muscle relaxation and halts spontaneous respiration.
- Phase 3 (Terminal Cardiorespiratory Arrest): Finally, the lethal bolus of Potassium Acetate was applied (Image 8), inducing immediate systemic hyperkalemia resulting in the definitive cessation of myocardial electrical activity and terminal cardiac arrest.
The procedure concluded without technical incidents. Final monitoring confirmed the state of irreversible cardiorespiratory arrest, fully complying with the rigorous institutional standards governing my position.